These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23143508)

  • 41. [Recommendations for the diagnosis and management of osteoporosis].
    Tavares V; Canhão H; Gomes JA; Simões E; Romeu JC; Coelho P; Santos RA; Malcata A; Araújo D; Vaz C; Branco J;
    Acta Reumatol Port; 2007; 32(1):49-59. PubMed ID: 17450765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical application of biochemical markers of bone turnover.
    Seibel MJ
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):603-20. PubMed ID: 17117286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemical markers of bone turnover.
    Delmas PD
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S549-55. PubMed ID: 8122526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First update of the Lebanese guidelines for osteoporosis assessment and treatment.
    El-Hajj Fuleihan G; Baddoura R; Awada H; Arabi A; Okais J
    J Clin Densitom; 2008; 11(3):383-96. PubMed ID: 18448373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.
    Cavalier E; Bergmann P; Bruyère O; Delanaye P; Durnez A; Devogelaer JP; Ferrari SL; Gielen E; Goemaere S; Kaufman JM; Toukap AN; Reginster JY; Rousseau AF; Rozenberg S; Scheen AJ; Body JJ
    Osteoporos Int; 2016 Jul; 27(7):2181-2195. PubMed ID: 27026330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteoporosis: therapeutic guidelines. Guidelines for practice management of osteoporosis.
    Khan SN; Craig L; Wild R
    Clin Obstet Gynecol; 2013 Dec; 56(4):694-702. PubMed ID: 24177062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lebanese guidelines for osteoporosis assessment and treatment: who to test? What measures to use? When to treat?
    Fuleihan Gel-H; Baddoura R; Awada H; Okais J; Rizk P; McClung M
    J Clin Densitom; 2005; 8(2):148-63. PubMed ID: 15908702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis.
    Vasikaran SD; Chubb SA
    Endocrine; 2016 May; 52(2):222-5. PubMed ID: 26906711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Proximal femoral BMD and measurement manual].
    Sone T
    Clin Calcium; 2008 Aug; 18(8):1114-8. PubMed ID: 18677048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis.
    Camacho PM; Lopez NA
    Clin Chem Lab Med; 2008; 46(10):1345-57. PubMed ID: 18844486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Can biochemical markers for bone density be recommended as diagnostic and prognostic tools in osteoporosis?].
    Midtby M; Magnus JH
    Tidsskr Nor Laegeforen; 1998 Feb; 118(4):575-9. PubMed ID: 9520586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prediction by early change of bone metabolic markers of the efficacy of anti-osteoporotic drugs on bone mass in osteoporotic patients].
    Inaba M
    Clin Calcium; 2014 Mar; 24(3):379-84. PubMed ID: 24576934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk assessment for osteoporosis. II. Biochemical markers of bone turnover: bone resorption indices.
    Woitge HW; Seibel MJ
    Clin Lab Med; 2000 Sep; 20(3):503-25, vi. PubMed ID: 10986618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment goals of osteoporosis].
    Hosoi T
    Clin Calcium; 2014 Mar; 24(3):385-9. PubMed ID: 24576935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monitoring of osteoporosis therapy.
    Bruyère O; Reginster JY
    Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):835-41. PubMed ID: 25432355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical Markers of Bone Turnover and their Role in Osteoporosis Diagnosis: A Narrative Review.
    Khashayar P; Meybodi HA; Amoabediny G; Larijani B
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):79-89. PubMed ID: 26246012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Current research in adequate treatment by Osteoporosis Research Group].
    Orimo H; Miyakawa N; Kuroda T
    Clin Calcium; 2006 Sep; 16(9):1500-7. PubMed ID: 16951475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Teaching about practice guidelines: osteoporosis].
    Sommer J; Uebelhart B
    Rev Med Suisse; 2011 May; 7(295):1070, 1072-4, 1076-7. PubMed ID: 21688673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Bone mineral measurements and guideline].
    Fukunaga M; Sone T
    Clin Calcium; 2008 Aug; 18(8):1089-95. PubMed ID: 18677045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.